Abiopharma

🔍 Regrut Andrew Donald (Executive)

Company: Kimball Electronics, Inc. (KE)

Report Date: 2026-08-24

Detailed Transactions and Holdings:

• Acquired 1,878 shares of Common Stock (Direct)
  Date: 2026-08-24 | Code: M | equity_swap_involved: 0 | shares_owned_after: 7,257.00 | transaction_form_type: 4
• Acquired 3,623 shares of Common Stock (Direct)
  Date: 2026-08-24 | Code: A | equity_swap_involved: 0 | shares_owned_after: 10,880.00 | transaction_form_type: 4 | Footnotes: F1
• Sold 2,153 shares of Common Stock at $22.725 per share (Direct)
  Date: 2026-08-24 | Code: F | equity_swap_involved: 0 | shares_owned_after: 8,727.00 | transaction_form_type: 4 | Footnotes: F2
• Sold 1,878 shares of Restricted Shares (Derivative)
  Date: 2026-08-24 | Code: M | equity_swap_involved: 0 | shares_owned_after: 3,417.00 | transaction_form_type: 4 | Footnotes: F3, F3
• Acquired 4,104 shares of Restricted Shares (Derivative)
  Date: 2026-08-24 | Code: A | equity_swap_involved: 0 | shares_owned_after: 7,521.00 | transaction_form_type: 4 | Footnotes: F6, F4, F5, F7

Footnotes:

• F1: Reflects performance based shares granted pursuant to the Issuer's 2023 Equity Incentive Plan which vested on August 24, 2026 upon the achievement of certain performance criteria certified by the Talent, Culture, and Compensation Committee of the Board of Directors of the Issuer.
• F2: Shares withheld to satisfy tax obligations.
• F3: Represents Restricted Shares granted in a prior year that vested on August 24, 2026 (1,878 shares).
• F4: Represents Restricted Shares which vest in August 2027 (1,368 shares), August 2028 (1,368 shares), and August 2029 (1,368 shares).
• F5: The Restricted Shares expire if the reporting person ceases employment for any reason other than death, disability, or retirement.
• F6: Not Applicable.
• F7: Represents cumulative Restricted Shares that vest June 2027 (1,053 shares), August 2027 (2,898 shares), August 2028 (2,202 shares), and August 2029 (1,368 shares).